Jerusalem Pharmaceuticals Co. Ltd. Stock Price

Jerusalem Pharmaceuticals Co. Ltd., together with its subsidiaries, develops, manufactures, and markets pharmaceutical products in Palestine, the Middle East, North Africa, and internationally. The company offers over the counter, prescription pharmaceutical, and nutritional supplements products in various dosage forms, including tablets, capsules, sterile injectables, powders for suspensions, suspensions, syrups, powders, suppositories, ovules, creams, and ointments, as well as ear and nose drops and solutions. It also provides medical devices; detergent; cosmetic; personal hygiene; veterinary; and agricultural products, as well as engages in printing services. The company’s products are used in cardiovascular, gastrointestinal and metabolic, respiratory, analgesic and musculoskeletal, dermatology, central nervous system, anti-infective, and oncology therapeutic areas. It operates in Jordan, Algeria, the Kingdom of Saudi Arabia, the United Arab Emirates, Lebanon, Iraq, Qatar, Kuwait, Bahrain, Oman, Yemen, Sudan, Ethiopia, Ivory Coast, Libya, Belarus, and other countries. The company was founded in 1969 and is headquartered in Ramallah, Palestinian Authority.